News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Daily News Genomics, Lipids, Inflammation at Midlife Predict Future CAD Caitlin E. Cox March 25, 2026
News Daily News Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk Yael L. Maxwell March 19, 2026
News Daily News Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines Michael O'Riordan March 13, 2026
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Daily News Biomarkers Added to a Polygenic Risk Score Equals Better CAD Prediction Yael L. Maxwell October 23, 2025
News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News ESC 2025 Olezarsen Brings Moderately High Triglycerides Under Control: Essence-TIMI 73b Caitlin E. Cox August 31, 2025
News Conference News ESC 2025 High hs-CRP Linked to More CVD Events in Women Lacking Traditional Risk Factors Caitlin E. Cox August 29, 2025
News Daily News New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists Yael L. Maxwell August 14, 2025
News Daily News PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors Michael O'Riordan July 18, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Daily News PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a) Michael O'Riordan June 10, 2025
News Daily News Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION Michael O'Riordan June 04, 2025